BlackRock Fund Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

BlackRock Fund Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$256K	Buy	7,769 +207	+3%	+$6.82K	﹤0.01%	3361
2016 Q3	$310K	Sell	7,562 -21	-0.3%	-$824	﹤0.01%	3321
2016 Q2	$249K	Sell	7,583 -63,551	-89%	-$2.33M	﹤0.01%	3384
2016 Q1	$4.41M	Sell	71,134 -1,210	-2%	-$38.4K	﹤0.01%	2808
2015 Q4	$3.05M	Buy	72,344 +1,907	+3%	+$90.9K	﹤0.01%	3037
2015 Q3	$3.86M	Buy	70,437 +9,244	+15%	+$917K	﹤0.01%	2927
2015 Q2	$6.72M	Buy	61,193 +42,329	+224%	+$3.93M	﹤0.01%	2743
2015 Q1	$1.79M	Buy	18,864 +5,287	+39%	+$373K	﹤0.01%	3154
2014 Q4	$760K	Buy	13,577 +1,867	+16%	+$128K	﹤0.01%	3234
2014 Q3	$848K	Sell	11,710 -483	-4%	-$52.9K	﹤0.01%	3200
2014 Q2	$1.83M	Sell	12,193 -1,137	-9%	-$173K	﹤0.01%	3131
2014 Q1	$1.94M	Buy	+13,330	New	+$1.63M	﹤0.01%	3141

Other funds holding GNCA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

BlackRock Fund Advisors's GNCA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Genocea Biosciences, Inc. (GNCA) stake by 2.7% in Q4 2016, buying an estimated $6.82K and bringing the position to 7,769 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #3361.

BlackRock Fund Advisors first reported a position in GNCA in Q1 2014 and has held it in 12 quarters since. The position peaked at $6.72M in Q2 2015. 47 funds tracked by Wall St. Rank hold GNCA as of Q4 2016.

BlackRock Fund Advisors held 7,769 shares of Genocea Biosciences, Inc. worth $256K as of Q4 2016.
BlackRock Fund Advisors bought 207 Genocea Biosciences, Inc. shares in Q4 2016, an estimated $6.82K.
Genocea Biosciences, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3361 holding.
BlackRock Fund Advisors first reported a position in Genocea Biosciences, Inc. in Q1 2014 and has held it in 12 quarters since.
BlackRock Fund Advisors's Genocea Biosciences, Inc. position peaked at $6.72M in Q2 2015.
47 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.